Thrombospondin 1, produced by endothelial cells under the action of erythropoietin, stimulates thymidine incorporation into erythroid cells and counteracts the inhibitory action of insulin-like growth factor binding protein 3

Cytokine

Volumn 30, Issue 5, 2005, Pages 248-253

  Congote, Luis F ^a   DiFalco, Marcos R ^b   Gibbs, Bernard F ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MDS Inc   (Canada)

Author keywords

Erythropoiesis; IGF; Platelets; Serum

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 3; SOMATOMEDIN BINDING PROTEIN 3; THROMBOSPONDIN 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CYTOKINE PRODUCTION; DNA SYNTHESIS; ENDOTHELIUM CELL; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; INCUBATION TIME; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN;

ANIMALS; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; ERYTHROID CELLS; ERYTHROPOIETIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INTERLEUKIN-3; PEPTIDE FRAGMENTS; THROMBOSPONDIN 1; THYMIDINE; UMBILICAL CORD;

BOVINAE;

EID: 20144378232     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.01.017     Document Type: Article

References (25)

1. M.R. DiFalco, and L.F. Congote Preparation of a recombinant chimera of insulin-like growth factor II and interleukin 3 with high proliferative potency for hematopoietic cells Biochem J 326 1997 407 413
2. M.R. DiFalco, L. Dufresne, and L.F. Congote Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice J Pharmacol Exp Ther 284 1998 449 454
3. M.R. DiFalco, and L.F. Congote Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells Cytokine 18 2002 51 60
4. V.S. Gallicchio, N.K. Hughes, and K.F. Tse In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine Cytokine 5 1993 62 71
5. S.R. Gogu, B.S. Beckman, R.B. Wilson, and K.C. Agrawal Inhibitory effects of zidovudine in erythroid progenitor cells. Reversal with a combination of erythropoietin and interleukin-3 Biochem Pharmacol 50 1995 413 419
6. F.J. Candal, S. Rafii, J.T. Parker, E.W. Ades, B. Ferris, and R.L. Nachman BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics Microvasc Res 52 1996 221 234
7. E.E. Anggard The endothelium - the body's largest endocrine gland? J Endocrinol 127 1990 371 375
8. L.F. Congote, M.R. Difalco, and B.F. Gibbs The C-terminal peptide of thrombospondin-4 stimulates erythroid cell proliferation Biochem Biophys Res Commun 324 2004 673 678
9. M. Fodinger, R. Fritsche-Polanz, H. Buchmayer, S. Skoupy, G. Sengoelge, and W.H. Horl Erythropoietin-inducible immediate-early genes in human vascular endothelial cells J Investig Med 48 2000 137 149
10. H. Chen, M.E. Herndon, and J. Lawler The cell biology of thrombospondin-1 Matrix Biol 19 2000 597 614
11. J. Lawler The functions of thrombospondin-1 and -2 Curr Opin Cell Biol 12 2000 634 640
12. C.R. Cogle, and E.W. Scott The hemangioblast: cradle to clinic Exp Hematol 32 2004 885 890
13. J. Dawes, K.J. Clemetson, G.O. Gogstad, J. McGregor, P. Clezardin, and C.V. Prowse A radioimmunoassay for thrombospondin used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers Thromb Res 29 1983 569 581
14. K.J. Kao, and P.A. Klein A monoclonal antibody-based enzyme-linked immunosorbent assay for quantitation of plasma thrombospondin Am J Clin Pathol 86 1986 317 323
15. M.D. Kosfeld, and W.A. Frazier Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin J Biol Chem 268 1993 8808 8814
16. D.W. Dawson, O.V. Volpert, S.F. Pearce, A.J. Schneider, R.L. Silverstein, and J. Henkin Three distinct d-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat Mol Pharmacol 55 1999 332 338
17. L.F. Congote, A. Brox, F.K. Lin, H.S. Lu, and A.A. Fauser The N-terminal sequence of the major erythropoietic factor of an anephric patient is identical to insulin-like growth factor I J Clin Endocrinol Metab 72 1991 727 729
18. Q. Li, R. Blacher, F. Esch, and L.F. Congote A heparin-binding erythroid cell stimulating factor from fetal bovine serum has the N-terminal sequence of insulin-like growth factor II Biochem Biophys Res Commun 166 1990 557 561
19. L.A. Maile, and D.R. Clemmons Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells Circ Res 93 2003 925 931
20. Perks CM, Clark M, Lawrence NJ, Winters Z, Burrows C, Holly JM. Intrinsic actions of IGFBP-3 in human breast epithelial cells involves modulation of integrin signalling. 85th annual meeting of the Endocrine Society, Philadelphia Abstract 395; 2003.
21. Q. Li, and L.F. Congote Bovine fetal-liver stromal cells support erythroid colony formation: enhancement by insulin-like growth factor II Exp Hematol 23 1995 66 73
22. J. Malyszko, S. Wolczynski, E. Zbroch, S. Brzosko, J. Malyszko, and M. Mysliwiec Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients Nephron 90 2002 282 289
23. R. De Maria, A. Zeuner, A. Eramo, C. Domenichelli, D. Bonci, and F. Grignani Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 Nature 401 1999 489 493
24. M.R. DiFalco, S. Ali, and L.F. Congote The improved survival of hematopoietic cells cultured with a fusion protein of insulin-like growth factor II and interleukin 3 is associated with increases in Bcl-xL and phosphatidylinositol 3 kinase activity J Leukoc Biol 73 2003 297 305
25. H. Curtis, C. Sandoval, C. Oblin, M.R. Difalco, and L.F. Congote Insect cell production of a secreted form of human alpha(1)-proteinase inhibitor as a bifunctional protein which inhibits neutrophil elastase and has growth factor-like activities J Biotechnol 93 2002 35 44